CytoReason
Develops a computational model of the human body for drug discovery and development.
About
CytoReason builds comprehensive computational disease models to map disease and drug mechanisms. Their platform enables pharmaceutical and biotech companies to manage drug portfolios, prioritize programs, and compare treatments across patient populations by integrating human data for predictable drug development. This allows scientists to gain deep drug profiles and executives to have a bird's-eye view of their entire portfolio. Teams look it up for Healthcare, Drug Discovery, Clinical Development.
Frequently asked
What does CytoReason do?
CytoReason is a Healthcare company that offers Software. Teams look it up for Drug Discovery, Clinical Development, Biomarkers. It is based in Tel Aviv, Israel and was founded in 2016. Public records show about 116 people and $128M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has CytoReason raised?
CytoReason has raised a total of $128M in funding. The most recent round on record is Series B.
Where is CytoReason headquartered?
CytoReason is headquartered in Tel Aviv, Israel.
When was CytoReason founded?
CytoReason was founded in 2016.
What industry does CytoReason operate in?
CytoReason operates in Healthcare, Drug Discovery, Clinical Development, Biomarkers, Target Discovery.
How many employees does CytoReason have?
CytoReason has approximately 116 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.